Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma
NCT01617746Phase 2Unknown
- Sponsor
- University of Glasgow
- Start
- Nov 2012
- Primary completion
- May 2014
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ambrisentan, bosentan in asthma, sponsored by University of Glasgow. Status: unknown.
02
Drugs
ambrisentanbosentan
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01617746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617746.